Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,320.00    250.00 (4.93%)
Bid:
5,305.00
Ask:
5,320.00
Spread: 15.00 (0.283%)
Market Cap: $1.40t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Decision on Share Repurchase

18 Mar 2026 08:28

RNS Number : 1318X
Samsung Electronics Co. Ld
18 March 2026
 

Decision on Share Repurchase

1. Number of shares to be repurchased

Common

37,000,000

Other

-

2. Value of shares to be repurchased (Korean won)

Common

7,174,300,000,000

Other

-

3. Expected repurchase period

Start date

March 19, 2026

End date

June 18, 2026

4. Expected holding period

Start date

-

End date

-

5. Purpose of repurchase

To facilitate employee stock-based compensation

6. Method of repurchase

Open market

7. Consignment investment brokers

Samsung Securities Co., Ltd.

Shinhan Securities Co., Ltd.

KB Securities Co., Ltd.

8. Holding status of treasury shares before repurchase

Repurchase within the allowable distribution profit (shares)

Common

120,813,769

Ratio (%)

2.0

Other

13,603,461

Ratio (%)

1.7

Other repurchase (shares)

Common

-

Ratio (%)

-

Other

-

Ratio (%)

-

9. Date of board resolution (confirmation date)

March 18, 2026

- Attendance of Independent Directors at the Board of Directors meeting

Present

5

Absent

-

- Attendance of auditors who are not

 Independent Directors

-

10. Daily order quantity limit

Common

8,656,922

Other

-

 

11. Other information to consider:

- Shares denoted as "other" are preferred shares.

- In Item 1 above, number of shares to be purchased was calculated based on the closing price on the day prior to the Board's resolution (March 17, 2026).

(KRW 193,900 per common share)

- The Company plans to acquire treasury shares based on the value of shares to be repurchased in Item 2 above. The actual amount may change depending on future stock price movements.

- With respect to Items 4 and Items 5 above, the Company is repurchasing shares that will be held in treasury for use in stock-based compensation programs, including Performance Stock Units (PSUs; introduced in October 2025) as well as in other programs to incentivize employee performance (e.g., OPI, LTI).

- In Item 9 above, all Audit Committee members are Independent Directors.

- The calculation method for Item 10 above is the smaller of: [] and [the larger of and ].

  10% of the number of shares to be repurchased: 3,700,000 common

  25% of average daily transaction volume over the one month period preceding the date of the board resolution: 8,656,922 common

  1% of total number of issued shares: 59,196,379 common

 

- Limit on the amount of repurchased shares (Korean won)

1. Limits to Dividend eligible profit under Commercial Act as of end-2025

243,066,826,669,885

2. Amount of repurchased shares since end-2025

6,073,607,225,640

3. Amount of dividends on profits and reserves for related profits decided at a general meeting of shareholders since end-2025

3,753,484,329,311

4. The interim dividend amount and related profit reserves decided by the board of directors since end-2025

-

5. Acquisition cost of the shares in disposing of treasury shares since end-2025

826,550,373,780

Limit on the amount of repurchased shares

(1-2-3-4+5)

234,066,285,488,714

- In Item 1 above, 'Limits to Dividend eligible profit under Commercial Act as of end-2025' is based on the 2025 financial statements approved at the general meeting of shareholders as of the report submission date (March 18, 2026)

-In Item 2 above, 'Amount of repurchased shares since end-2025' represents the book value, including related fees and expenses

 

- Holding status of treasury shares before purchase (number of shares)

* on-market direct purchase

Stock type

Initial quantity

Changes

End quantity

Purchase

Disposal

Cancellation

Common

91,828,987

36,793,671

7,808,889

-

120,813,769

Other

13,603,461

-

-

-

13,603,461

 

* The 'Initial quantity' represents the number of shares held on as of January 1, 2026, the first day of the fiscal year in which the disclosure document was prepared; and the 'End quantity' refers to the number of shares held on March 18, 2026, the day the disclosure document was prepared.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMFRRDGVZG
Date   Source Headline
31st Oct 20249:02 amRNSDelisting and Listing of Stocks
31st Oct 20247:00 amRNSQuarterly Dividend for Third Quarter 2024
31st Oct 20247:00 amRNS2024 3Q Earnings Release
31st Oct 20247:00 amRNSAnnouncement of Capex Plan for FY2024
8th Oct 20247:00 amRNSNotice of 3Q 2024 Earning Release
8th Oct 20247:00 amRNS3Q 2024 Pre-Earnings Guidance
30th Aug 202410:52 amRNS2024 Half-year Business Report
31st Jul 20249:33 amRNSTransaction with Affiliate Company
31st Jul 20249:26 amRNSCharitable Contribution
31st Jul 20247:00 amRNSQuarterly Dividend for Second Quarter 2024
31st Jul 20247:00 amRNS2024 2Q Earnings Release
5th Jul 20247:55 amRNSNotice of 2Q 2024 Earnings Release Schedule
5th Jul 20247:45 amRNS2Q 2024 Pre-Earnings Guidance
28th Jun 20248:53 amRNSSustainability Report 2024
31st May 202410:23 amRNSCorporate Governance Report FY2023
31st May 20247:00 amRNS2024 1Q INTERIM BUSINESS REPORT
21st May 20249:34 amRNSNotice on Change of CEO
30th Apr 20248:10 amRNSTransactions with Affiliated Companies
30th Apr 20247:00 amRNSQuarterly Dividend for First Quarter 2024
30th Apr 20247:00 amRNS2024 1Q Earnings Release
30th Apr 20247:00 amRNS2023 Business Report
5th Apr 20247:11 amRNSNotice of 1Q 2024 Earnings Release Schedule
5th Apr 20247:00 amRNS1Q 2024 Pre-Earnings Guidance
20th Mar 20249:07 amRNSTransactions with Affiliated Companies
20th Mar 20249:05 amRNSResults of the 55th Annual General Meeting
21st Feb 20247:00 amRNSReference Material for 2024 AGM
20th Feb 20248:31 amRNSCharitable Contribution
19th Feb 20249:40 amRNS2023 Separate Financial Statements
19th Feb 20249:34 amRNS2023 Consolidated Financial Statements
31st Jan 20247:00 amRNSYear-End Dividend for FY2023
31st Jan 20247:00 amRNS2023 4Q Earning Release
31st Jan 20247:00 amRNSTransactions with Affiliated Companies
31st Jan 20247:00 amRNSShareholder Return Program for FY2024-2026
31st Jan 20247:00 amRNSAnnouncement of Capex Result for FY2023
9th Jan 20247:00 amRNSNotice of 4Q 2023 Earning Release
9th Jan 20247:00 amRNS4Q 2023 Pre-Earnings Guidance
1st Dec 202311:09 amRNSCharitable Contribution
30th Nov 20237:54 amRNSTransactions with Affiliated Companies
30th Nov 20237:34 amRNS2023 3Q Interim Business Report
6th Nov 20238:43 amRNSAnnouncement of Investor Relations Event
31st Oct 20237:21 amRNSTransactions with Affiliated Companies
31st Oct 20237:18 amRNSAnnouncement of Capex Plan for FY2023
31st Oct 20237:13 amRNSQuarterly Dividend for Third Quarter 2023
31st Oct 20237:10 amRNS2023 3Q Earning Release
11th Oct 20237:10 amRNSNotice of 3Q 2023 Earning Release
11th Oct 20237:04 amRNS3Q 2023 Pre-Earnings Guidance
21st Sep 20237:30 amRNS2022 Business Report
21st Sep 20237:29 amRNS2022 Separate Financial Statements
21st Sep 20237:29 amRNS2022 Consolidated Financial Statements
31st Aug 20238:15 amRNS2023 Half-year Business Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.